Global and China Anti-Infective Therapy Market Size, Status and Forecast 2024-2031

Report ID: 1025181 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-Infective Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Penicillin
        1.2.3 Sulphonamides
        1.2.4 Aminoglycosides
        1.2.5 Fluoroquinolones
        1.2.6 Antifungals
        1.2.7 Antiprotozoal
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Anti-Infective Therapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Home User
        1.3.3 Hospitals/Clinics
        1.3.4 Ambulatory Surgery Centres
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Anti-Infective Therapy Market Perspective (2016-2027)
    2.2 Anti-Infective Therapy Growth Trends by Regions
        2.2.1 Anti-Infective Therapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Anti-Infective Therapy Historic Market Share by Regions (2016-2021)
        2.2.3 Anti-Infective Therapy Forecasted Market Size by Regions (2022-2027)
    2.3 Anti-Infective Therapy Industry Dynamic
        2.3.1 Anti-Infective Therapy Market Trends
        2.3.2 Anti-Infective Therapy Market Drivers
        2.3.3 Anti-Infective Therapy Market Challenges
        2.3.4 Anti-Infective Therapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Anti-Infective Therapy Players by Revenue
        3.1.1 Global Top Anti-Infective Therapy Players by Revenue (2016-2021)
        3.1.2 Global Anti-Infective Therapy Revenue Market Share by Players (2016-2021)
    3.2 Global Anti-Infective Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Anti-Infective Therapy Revenue
    3.4 Global Anti-Infective Therapy Market Concentration Ratio
        3.4.1 Global Anti-Infective Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Therapy Revenue in 2020
    3.5 Anti-Infective Therapy Key Players Head office and Area Served
    3.6 Key Players Anti-Infective Therapy Product Solution and Service
    3.7 Date of Enter into Anti-Infective Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-Infective Therapy Breakdown Data by Type
    4.1 Global Anti-Infective Therapy Historic Market Size by Type (2016-2021)
    4.2 Global Anti-Infective Therapy Forecasted Market Size by Type (2022-2027)

5 Anti-Infective Therapy Breakdown Data by Application
    5.1 Global Anti-Infective Therapy Historic Market Size by Application (2016-2021)
    5.2 Global Anti-Infective Therapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Anti-Infective Therapy Market Size (2016-2027)
    6.2 North America Anti-Infective Therapy Market Size by Type
        6.2.1 North America Anti-Infective Therapy Market Size by Type (2016-2021)
        6.2.2 North America Anti-Infective Therapy Market Size by Type (2022-2027)
        6.2.3 North America Anti-Infective Therapy Market Size by Type (2016-2027)
    6.3 North America Anti-Infective Therapy Market Size by Application
        6.3.1 North America Anti-Infective Therapy Market Size by Application (2016-2021)
        6.3.2 North America Anti-Infective Therapy Market Size by Application (2022-2027)
        6.3.3 North America Anti-Infective Therapy Market Size by Application (2016-2027)
    6.4 North America Anti-Infective Therapy Market Size by Country
        6.4.1 North America Anti-Infective Therapy Market Size by Country (2016-2021)
        6.4.2 North America Anti-Infective Therapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Anti-Infective Therapy Market Size (2016-2027)
    7.2 Europe Anti-Infective Therapy Market Size by Type
        7.2.1 Europe Anti-Infective Therapy Market Size by Type (2016-2021)
        7.2.2 Europe Anti-Infective Therapy Market Size by Type (2022-2027)
        7.2.3 Europe Anti-Infective Therapy Market Size by Type (2016-2027)
    7.3 Europe Anti-Infective Therapy Market Size by Application
        7.3.1 Europe Anti-Infective Therapy Market Size by Application (2016-2021)
        7.3.2 Europe Anti-Infective Therapy Market Size by Application (2022-2027)
        7.3.3 Europe Anti-Infective Therapy Market Size by Application (2016-2027)
    7.4 Europe Anti-Infective Therapy Market Size by Country
        7.4.1 Europe Anti-Infective Therapy Market Size by Country (2016-2021)
        7.4.2 Europe Anti-Infective Therapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Anti-Infective Therapy Market Size (2016-2027)
    8.2 Asia-Pacific Anti-Infective Therapy Market Size by Type
        8.2.1 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Anti-Infective Therapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Anti-Infective Therapy Market Size by Application
        8.3.1 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Anti-Infective Therapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Anti-Infective Therapy Market Size by Region
        8.4.1 Asia-Pacific Anti-Infective Therapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Anti-Infective Therapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Anti-Infective Therapy Market Size (2016-2027)
    9.2 Latin America Anti-Infective Therapy Market Size by Type
        9.2.1 Latin America Anti-Infective Therapy Market Size by Type (2016-2021)
        9.2.2 Latin America Anti-Infective Therapy Market Size by Type (2022-2027)
        9.2.3 Latin America Anti-Infective Therapy Market Size by Type (2016-2027)
    9.3 Latin America Anti-Infective Therapy Market Size by Application
        9.3.1 Latin America Anti-Infective Therapy Market Size by Application (2016-2021)
        9.3.2 Latin America Anti-Infective Therapy Market Size by Application (2022-2027)
        9.3.3 Latin America Anti-Infective Therapy Market Size by Application (2016-2027)
    9.4 Latin America Anti-Infective Therapy Market Size by Country
        9.4.1 Latin America Anti-Infective Therapy Market Size by Country (2016-2021)
        9.4.2 Latin America Anti-Infective Therapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Anti-Infective Therapy Market Size (2016-2027)
    10.2 Middle East & Africa Anti-Infective Therapy Market Size by Type
        10.2.1 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Anti-Infective Therapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Anti-Infective Therapy Market Size by Application
        10.3.1 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Anti-Infective Therapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Anti-Infective Therapy Market Size by Country
        10.4.1 Middle East & Africa Anti-Infective Therapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Anti-Infective Therapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories Ltd.
        11.1.1 Abbott Laboratories Ltd. Company Details
        11.1.2 Abbott Laboratories Ltd. Business Overview
        11.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Introduction
        11.1.4 Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
        11.1.5 Abbott Laboratories Ltd. Recent Development
    11.2 Cipla Ltd.
        11.2.1 Cipla Ltd. Company Details
        11.2.2 Cipla Ltd. Business Overview
        11.2.3 Cipla Ltd. Anti-Infective Therapy Introduction
        11.2.4 Cipla Ltd. Revenue in Anti-Infective Therapy Business (2016-2021)
        11.2.5 Cipla Ltd. Recent Development
    11.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
        11.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
        11.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
        11.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Introduction
        11.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2016-2021)
        11.3.5 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
    11.4 Glenmark Pharmaceuticals Limited
        11.4.1 Glenmark Pharmaceuticals Limited Company Details
        11.4.2 Glenmark Pharmaceuticals Limited Business Overview
        11.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Introduction
        11.4.4 Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2016-2021)
        11.4.5 Glenmark Pharmaceuticals Limited Recent Development
    11.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
        11.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
        11.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
        11.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Introduction
        11.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2016-2021)
        11.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
    11.6 Lupin Limited
        11.6.1 Lupin Limited Company Details
        11.6.2 Lupin Limited Business Overview
        11.6.3 Lupin Limited Anti-Infective Therapy Introduction
        11.6.4 Lupin Limited Revenue in Anti-Infective Therapy Business (2016-2021)
        11.6.5 Lupin Limited Recent Development
    11.7 Panacea Biotec Limited
        11.7.1 Panacea Biotec Limited Company Details
        11.7.2 Panacea Biotec Limited Business Overview
        11.7.3 Panacea Biotec Limited Anti-Infective Therapy Introduction
        11.7.4 Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2016-2021)
        11.7.5 Panacea Biotec Limited Recent Development
    11.8 Novartis AG
        11.8.1 Novartis AG Company Details
        11.8.2 Novartis AG Business Overview
        11.8.3 Novartis AG Anti-Infective Therapy Introduction
        11.8.4 Novartis AG Revenue in Anti-Infective Therapy Business (2016-2021)
        11.8.5 Novartis AG Recent Development
    11.9 Pfizer, Inc.
        11.9.1 Pfizer, Inc. Company Details
        11.9.2 Pfizer, Inc. Business Overview
        11.9.3 Pfizer, Inc. Anti-Infective Therapy Introduction
        11.9.4 Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2016-2021)
        11.9.5 Pfizer, Inc. Recent Development
    11.10 Ranbaxy Laboratories Limited
        11.10.1 Ranbaxy Laboratories Limited Company Details
        11.10.2 Ranbaxy Laboratories Limited Business Overview
        11.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Introduction
        11.10.4 Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2016-2021)
        11.10.5 Ranbaxy Laboratories Limited Recent Development
    11.11 Sun Pharmaceutical Industries Limited
        11.11.1 Sun Pharmaceutical Industries Limited Company Details
        11.11.2 Sun Pharmaceutical Industries Limited Business Overview
        11.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Introduction
        11.11.4 Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2016-2021)
        11.11.5 Sun Pharmaceutical Industries Limited Recent Development
    11.12 AstraZeneca plc
        11.12.1 AstraZeneca plc Company Details
        11.12.2 AstraZeneca plc Business Overview
        11.12.3 AstraZeneca plc Anti-Infective Therapy Introduction
        11.12.4 AstraZeneca plc Revenue in Anti-Infective Therapy Business (2016-2021)
        11.12.5 AstraZeneca plc Recent Development
    11.13 Johnson & Johnson
        11.13.1 Johnson & Johnson Company Details
        11.13.2 Johnson & Johnson Business Overview
        11.13.3 Johnson & Johnson Anti-Infective Therapy Introduction
        11.13.4 Johnson & Johnson Revenue in Anti-Infective Therapy Business (2016-2021)
        11.13.5 Johnson & Johnson Recent Development
    11.14 WOCKHARDT
        11.14.1 WOCKHARDT Company Details
        11.14.2 WOCKHARDT Business Overview
        11.14.3 WOCKHARDT Anti-Infective Therapy Introduction
        11.14.4 WOCKHARDT Revenue in Anti-Infective Therapy Business (2016-2021)
        11.14.5 WOCKHARDT Recent Development
    11.15 F. Hoffmann-La Roche Ltd
        11.15.1 F. Hoffmann-La Roche Ltd Company Details
        11.15.2 F. Hoffmann-La Roche Ltd Business Overview
        11.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Introduction
        11.15.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2016-2021)
        11.15.5 F. Hoffmann-La Roche Ltd Recent Development
    11.16 Sanofi
        11.16.1 Sanofi Company Details
        11.16.2 Sanofi Business Overview
        11.16.3 Sanofi Anti-Infective Therapy Introduction
        11.16.4 Sanofi Revenue in Anti-Infective Therapy Business (2016-2021)
        11.16.5 Sanofi Recent Development
    11.17 Merck
        11.17.1 Merck Company Details
        11.17.2 Merck Business Overview
        11.17.3 Merck Anti-Infective Therapy Introduction
        11.17.4 Merck Revenue in Anti-Infective Therapy Business (2016-2021)
        11.17.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Anti-Infective Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Penicillin
    Table 3. Key Players of Sulphonamides
    Table 4. Key Players of Aminoglycosides
    Table 5. Key Players of Fluoroquinolones
    Table 6. Key Players of Antifungals
    Table 7. Key Players of Antiprotozoal
    Table 8. Key Players of Others
    Table 9. Global Anti-Infective Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Anti-Infective Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Anti-Infective Therapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Anti-Infective Therapy Market Share by Regions (2016-2021)
    Table 13. Global Anti-Infective Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Anti-Infective Therapy Market Share by Regions (2022-2027)
    Table 15. Anti-Infective Therapy Market Trends
    Table 16. Anti-Infective Therapy Market Drivers
    Table 17. Anti-Infective Therapy Market Challenges
    Table 18. Anti-Infective Therapy Market Restraints
    Table 19. Global Anti-Infective Therapy Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Anti-Infective Therapy Market Share by Players (2016-2021)
    Table 21. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Therapy as of 2020)
    Table 22. Ranking of Global Top Anti-Infective Therapy Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Anti-Infective Therapy Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Anti-Infective Therapy Product Solution and Service
    Table 26. Date of Enter into Anti-Infective Therapy Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Anti-Infective Therapy Revenue Market Share by Type (2016-2021)
    Table 30. Global Anti-Infective Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Anti-Infective Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Anti-Infective Therapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Anti-Infective Therapy Revenue Market Share by Application (2016-2021)
    Table 34. Global Anti-Infective Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Anti-Infective Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Anti-Infective Therapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Anti-Infective Therapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Anti-Infective Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Anti-Infective Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Anti-Infective Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Anti-Infective Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Anti-Infective Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Anti-Infective Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Abbott Laboratories Ltd. Company Details
    Table 67. Abbott Laboratories Ltd. Business Overview
    Table 68. Abbott Laboratories Ltd. Anti-Infective Therapy Product
    Table 69. Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 70. Abbott Laboratories Ltd. Recent Development
    Table 71. Cipla Ltd. Company Details
    Table 72. Cipla Ltd. Business Overview
    Table 73. Cipla Ltd. Anti-Infective Therapy Product
    Table 74. Cipla Ltd. Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 75. Cipla Ltd. Recent Development
    Table 76. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
    Table 77. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
    Table 78. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product
    Table 79. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 80. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
    Table 81. Glenmark Pharmaceuticals Limited Company Details
    Table 82. Glenmark Pharmaceuticals Limited Business Overview
    Table 83. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product
    Table 84. Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 85. Glenmark Pharmaceuticals Limited Recent Development
    Table 86. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
    Table 87. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
    Table 88. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product
    Table 89. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 90. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
    Table 91. Lupin Limited Company Details
    Table 92. Lupin Limited Business Overview
    Table 93. Lupin Limited Anti-Infective Therapy Product
    Table 94. Lupin Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 95. Lupin Limited Recent Development
    Table 96. Panacea Biotec Limited Company Details
    Table 97. Panacea Biotec Limited Business Overview
    Table 98. Panacea Biotec Limited Anti-Infective Therapy Product
    Table 99. Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 100. Panacea Biotec Limited Recent Development
    Table 101. Novartis AG Company Details
    Table 102. Novartis AG Business Overview
    Table 103. Novartis AG Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 104. Novartis AG Recent Development
    Table 105. Pfizer, Inc. Company Details
    Table 106. Pfizer, Inc. Business Overview
    Table 107. Pfizer, Inc. Anti-Infective Therapy Product
    Table 108. Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 109. Pfizer, Inc. Recent Development
    Table 110. Ranbaxy Laboratories Limited Company Details
    Table 111. Ranbaxy Laboratories Limited Business Overview
    Table 112. Ranbaxy Laboratories Limited Anti-Infective Therapy Product
    Table 113. Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 114. Ranbaxy Laboratories Limited Recent Development
    Table 115. Sun Pharmaceutical Industries Limited Company Details
    Table 116. Sun Pharmaceutical Industries Limited Business Overview
    Table 117. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product
    Table 118. Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 119. Sun Pharmaceutical Industries Limited Recent Development
    Table 120. AstraZeneca plc Company Details
    Table 121. AstraZeneca plc Business Overview
    Table 122. AstraZeneca plc Anti-Infective Therapy Product
    Table 123. AstraZeneca plc Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 124. AstraZeneca plc Recent Development
    Table 125. Johnson & Johnson Company Details
    Table 126. Johnson & Johnson Business Overview
    Table 127. Johnson & Johnson Anti-Infective Therapy Product
    Table 128. Johnson & Johnson Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 129. Johnson & Johnson Recent Development
    Table 130. WOCKHARDT Company Details
    Table 131. WOCKHARDT Business Overview
    Table 132. WOCKHARDT Anti-Infective Therapy Product
    Table 133. WOCKHARDT Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 134. WOCKHARDT Recent Development
    Table 135. F. Hoffmann-La Roche Ltd Company Details
    Table 136. F. Hoffmann-La Roche Ltd Business Overview
    Table 137. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product
    Table 138. F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 139. F. Hoffmann-La Roche Ltd Recent Development
    Table 140. Sanofi Company Details
    Table 141. Sanofi Business Overview
    Table 142. Sanofi Anti-Infective Therapy Product
    Table 143. Sanofi Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 144. Sanofi Recent Development
    Table 145. Merck Company Details
    Table 146. Merck Business Overview
    Table 147. Merck Anti-Infective Therapy Product
    Table 148. Merck Revenue in Anti-Infective Therapy Business (2016-2021) & (US$ Million)
    Table 149. Merck Recent Development
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-Infective Therapy Market Share by Type: 2020 VS 2027
    Figure 2. Penicillin Features
    Figure 3. Sulphonamides Features
    Figure 4. Aminoglycosides Features
    Figure 5. Fluoroquinolones Features
    Figure 6. Antifungals Features
    Figure 7. Antiprotozoal Features
    Figure 8. Others Features
    Figure 9. Global Anti-Infective Therapy Market Share by Application: 2020 VS 2027
    Figure 10. Home User Case Studies
    Figure 11. Hospitals/Clinics Case Studies
    Figure 12. Ambulatory Surgery Centres Case Studies
    Figure 13. Others Case Studies
    Figure 14. Anti-Infective Therapy Report Years Considered
    Figure 15. Global Anti-Infective Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Anti-Infective Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Anti-Infective Therapy Market Share by Regions: 2020 VS 2027
    Figure 18. Global Anti-Infective Therapy Market Share by Regions (2022-2027)
    Figure 19. Global Anti-Infective Therapy Market Share by Players in 2020
    Figure 20. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Therapy as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Anti-Infective Therapy Revenue in 2020
    Figure 22. Global Anti-Infective Therapy Revenue Market Share by Type (2016-2021)
    Figure 23. Global Anti-Infective Therapy Revenue Market Share by Type (2022-2027)
    Figure 24. North America Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Anti-Infective Therapy Market Share by Type (2016-2027)
    Figure 26. North America Anti-Infective Therapy Market Share by Application (2016-2027)
    Figure 27. North America Anti-Infective Therapy Market Share by Country (2016-2027)
    Figure 28. United States Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Anti-Infective Therapy Market Share by Type (2016-2027)
    Figure 32. Europe Anti-Infective Therapy Market Share by Application (2016-2027)
    Figure 33. Europe Anti-Infective Therapy Market Share by Country (2016-2027)
    Figure 34. Germany Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Anti-Infective Therapy Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Anti-Infective Therapy Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Anti-Infective Therapy Market Share by Region (2016-2027)
    Figure 44. China Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Anti-Infective Therapy Market Share by Type (2016-2027)
    Figure 52. Latin America Anti-Infective Therapy Market Share by Application (2016-2027)
    Figure 53. Latin America Anti-Infective Therapy Market Share by Country (2016-2027)
    Figure 54. Mexico Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Anti-Infective Therapy Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Anti-Infective Therapy Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Anti-Infective Therapy Market Share by Country (2016-2027)
    Figure 60. Turkey Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Anti-Infective Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Abbott Laboratories Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 64. Cipla Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 65. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 66. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 67. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 68. Lupin Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 69. Panacea Biotec Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 70. Novartis AG Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 71. Pfizer, Inc. Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 72. Ranbaxy Laboratories Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 73. Sun Pharmaceutical Industries Limited Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 74. AstraZeneca plc Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 75. Johnson & Johnson Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 76. WOCKHARDT Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 77. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 78. Sanofi Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 79. Merck Revenue Growth Rate in Anti-Infective Therapy Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories Ltd.
Cipla Ltd.
Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
Glenmark Pharmaceuticals Limited
GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
Lupin Limited
Panacea Biotec Limited
Novartis AG
Pfizer, Inc.
Ranbaxy Laboratories Limited
Sun Pharmaceutical Industries Limited
AstraZeneca plc
Johnson & Johnson
WOCKHARDT
F. Hoffmann-La Roche Ltd
Sanofi
Merck
Frequently Asked Questions
Anti-Infective Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Infective Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Infective Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports